Raymond James Financial Services Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,385
Closed -$24K 3384
2022
Q1
$24K Buy
11,385
+1,050
+10% +$2.56K ﹤0.01% 3251
2021
Q4
$38K Sell
10,335
-2,857
-22% -$12.3K ﹤0.01% 3211
2021
Q3
$66K Buy
+13,192
New +$75.9K ﹤0.01% 3166
2020
Q2
Sell
-10,576
Closed -$36K 2884
2020
Q1
$36K Sell
10,576
-65,138
-86% -$281K ﹤0.01% 2340
2019
Q4
$415K Buy
75,714
+41,927
+124% +$236K ﹤0.01% 2097
2019
Q3
$193K Sell
33,787
-302
-0.9% -$2.05K ﹤0.01% 2518
2019
Q2
$261K Buy
34,089
+10,574
+45% +$56.9K ﹤0.01% 2353
2019
Q1
$124K Buy
23,515
+530
+2% +$3.67K ﹤0.01% 2616
2018
Q4
$150K Sell
22,985
-16,008
-41% -$179K ﹤0.01% 2334
2018
Q3
$671K Sell
38,993
-30,887
-44% -$459K ﹤0.01% 1710
2018
Q2
$974K Buy
69,880
+5,579
+9% +$94.2K 0.01% 1439
2018
Q1
$986K Buy
64,301
+2,131
+3% +$30.5K 0.01% 1307
2017
Q4
$716K Sell
62,170
-1,398
-2% -$20.8K ﹤0.01% 1498
2017
Q3
$1.21M Buy
63,568
+4,422
+7% +$91K 0.01% 1184
2017
Q2
$1.43M Buy
59,146
+2,468
+4% +$54.1K 0.01% 1043
2017
Q1
$1.12M Buy
56,678
+9,263
+20% +$207K 0.01% 1106
2016
Q4
$1.14M Sell
47,415
-1,809
-4% -$50.4K 0.01% 1039
2016
Q3
$1.37M Buy
49,224
+1,623
+3% +$42.9K 0.01% 927
2016
Q2
$1.16M Buy
47,601
+6,280
+15% +$178K 0.01% 957
2016
Q1
$1.39M Sell
41,321
-504
-1% -$15.9K 0.02% 771
2015
Q4
$1.25M Sell
41,825
-14,863
-26% -$501K 0.01% 829
2015
Q3
$1.79M Buy
+56,688
New +$2.77M 0.03% 562

Other funds holding PGEN

Raymond James Financial Services Advisors's PGEN Position: Q2 2022 in Review

Raymond James Financial Services Advisors sold out of Precigen (PGEN) in Q2 2022, closing a stake of 11,385 shares — an estimated $24K sold.

Raymond James Financial Services Advisors first reported a position in PGEN in Q3 2015 and held it in 22 quarters. The position peaked at $1.79M in Q3 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2022.

  • Raymond James Financial Services Advisors reported no remaining Precigen position as of Q2 2022 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 11,385 Precigen shares in Q2 2022, an estimated $24K.
  • Raymond James Financial Services Advisors first reported a position in Precigen in Q3 2015 and held it in 22 quarters.
  • Raymond James Financial Services Advisors's Precigen position peaked at $1.79M in Q3 2015.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.